Where does Miles Gerson work?

Miles Gerson is Partner at SV Health Investors at Dementia Discovery.

What does Miles Gerson invest in?

Miles Gerson invests in Biotech, Longevity.

Where did Miles Gerson go to school?

Miles Gerson studied at University of Wisconsin-Madison (Master of Business Administration - MBA, Strategic Management in the Life and Engineering Sciences); University of Wisconsin-Madison (Doctor of Law - JD, Intellectual Property); Copenhagen Business School (IP Strategy & Negotiations).

Miles Gerson

Investor

Partner at SV Health Investors at Dementia Discovery · Partner at Dementia Discovery Fund · Partner at SV Health Investors

USA

Find your path to Miles

302 people in our graph share verified history with Miles — schools, employers, funds. One of them is your warm intro.

Robert BlazejunlockedMiles: together at Nitrase Therapeutics (2026)

×2Miles: together at Quralis

×7Miles: together at Wesleyan University

Miles: together at SV Health Investors

About

Miles Gerson joined SV Health Investors as a partner in 2026 and co-leads the firm's Dementia Discovery Fund (DDF). He previously headed Takeda Ventures, where he oversaw a portfolio of more than 60 private and public life sciences investments and led the corporate venture group's global investment strategy, and also served on an interim basis as Takeda's Head of GI Business Development. Earlier in his career he was in founding management of early-stage companies and led investment diligence for venture and private equity firms in the US and Europe. He holds a JD/MBA from the University of Wisconsin-Madison and Bachelor's and Master's degrees in Neuroscience & Behavioral Studies from Wesleyan University.

Invests in

BiotechLongevity

Experience

SV Health Investors' Dementia Discovery Fund (DDF)Partner at SV Health Investorscurrent2026 — presentBoston, Massachusetts, United States
Integra TherapeuticsIndependent Chair of the Board of Directorscurrent2025 — presentBarcelona, Catalonia, Spain
Crosswalk TherapeuticsIndependent Chair of the Board of Directorscurrent2025 — presentCambridge, Massachusetts, United States
Violet TherapeuticsBoard Membercurrent2026 — present
Nitrase TherapeuticsBoard Membercurrent2026 — present
Sudo BiosciencesBoard Observercurrent2026 — present
QurAlisBoard Observercurrent2026 — present
Montara Therapeutics, Inc.Board Observercurrent2026 — present
Takeda Ventures, Inc.Global Head and President, Takeda Ventures2024 — 2025Cambridge, Massachusetts, United States
Takeda Ventures, Inc.Executive Investment Director & Partner2023 — 2024Cambridge, Massachusetts, United States
Takeda Ventures, Inc.Senior Investment Director & Partner2021 — 2023Cambridge, Massachusetts, United States
Takeda Ventures, Inc.Partner2020 — 2021
TakedaInterim Head of GI Business Development2021 — 2022
Viridian Therapeutics, Inc.Senior Director, Business Development & Legal Affairs; Corporate Counsel and Compliance Officer2016 — 2020Boulder, Colorado
Stark Advisor, Ltd.Founder and Principal - VC/PE Advisory2007 — 2020
CHD Bioscience, Inc.Vice President, Business & Corporate Development2015 — 2016Fort Collins, Colorado, United States
UCLA Technology Development GroupManaging Officer, Business Development2012 — 2015Los Angeles Metropolitan Area
TriSalus Life SciencesDirector of Finance & Administration; Corporate Secretary2010 — 2012Westminster, CO
High Country VentureVenture Capital Analyst2009 — 2011Boulder, Colorado
Fitzsimons BioBusiness PartnersAssociate (pro bono)2009 — 2011
Diabetes Sports and Wellness FoundationExecutive Director2005 — 2007
Satyapon & Partners (Bangkok, Thailand)Summer Legal Associate2007
EpicLegal Coordinator2004 — 2005

Skills & more

Corporate Venture CapitalStart-ups ManagementBoard of DirectorsDrug DiscoveryDrug DevelopmentMedical EthicsPublic PolicyDatabase AdministrationInternational RelationsNonprofit OrganizationsPhilanthropyEducation

+12 more

Diabetes ManagementSports CoachingEvent PlanningEvent ManagementPatent LawCopyright LawTrademark LawTrademark InfringementElectronic Medical Record (EMR)Team ManagementTeam LeadershipStrategy

From Miles's professional profile.

Colleagues at Dementia Discovery

Catherine Bingham

General Partner at Dementia Discovery

Christian Jung

Partner at Dementia Discovery

Damian Crowther

ex-AstraZeneca at PICUS CAPITAL

Dirk Landgraf

Principal at SV Health Investors

Dirk Landgraf

Principal at Dementia Discovery

Georgia Frost

Senior Associate at Dementia Discovery

Hamish Cameron

General Partner at Dementia Discovery

Huiyuan Zhang

Senior Associate at Dementia Discovery

Frequently asked questions

Who is Miles Gerson?: Miles Gerson joined SV Health Investors as a partner in 2026 and co-leads the firm's Dementia Discovery Fund (DDF). He previously headed Takeda Ventures, where he oversaw a portfolio of more than 60 private and public life sciences investments and led the corporate venture group's global investment strategy, and also served on an interim basis as Takeda's Head of GI Business Development. Earlier in his career he was in founding management of early-stage companies and led investment diligence for venture and private equity firms in the US and Europe. He holds a JD/MBA from the University of Wisconsin-Madison and Bachelor's and Master's degrees in Neuroscience & Behavioral Studies from Wesleyan University.
Where does Miles Gerson work?: Miles Gerson is Partner at SV Health Investors at Dementia Discovery.
What does Miles Gerson invest in?: Miles Gerson invests in Biotech, Longevity.
Where did Miles Gerson go to school?: Miles Gerson studied at University of Wisconsin-Madison (Master of Business Administration - MBA, Strategic Management in the Life and Engineering Sciences); University of Wisconsin-Madison (Doctor of Law - JD, Intellectual Property); Copenhagen Business School (IP Strategy & Negotiations).